'Classic triad' of symptoms misses positive COVID-19 cases, study finds

February 18, 2021

Extending the symptoms that trigger a PCR test for COVID-19 could help detect around a third more cases of the disease.

New research led by researchers at King's College London and published in the Journal of Infection suggests that restricting testing to the 'classic triad' of cough, fever and loss of smell which is required for eligibility for a PCR test through the NHS may have missed cases. Extending the list to include fatigue, sore throat, headache and diarrhoea would have detected 96% of symptomatic cases.

A team of researchers at King's College London and the Coalition for Epidemic Preparedness Innovations (CEPI) analysed data from more than 122,000 UK adult users of the ZOE COVID Symptom Study app. These users reported experiencing any potential COVID-19 symptoms, and 1,202 of those reported a positive PCR test within a week of first feeling ill.

While PCR swab testing is the most reliable way to tell whether someone is infected with the SARS-CoV-2 coronavirus that causes COVID-19, the analysis suggests the limited list of three does not catch all positive cases of COVID-19.

Testing people with any of the three 'classic' symptoms would have spotted 69% of symptomatic cases, with 46 people testing negative for every person testing positive. However, testing people with any of seven key symptoms - cough, fever, anosmia, fatigue, headache, sore throat and diarrhoea - in the first three days of illness would have detected 96% of symptomatic cases. In this case, for every person with the disease identified, 95 would test negative.

Researchers also found users of the Symptom Study App were more likely to select headache and diarrhoea within the first three days of symptoms, and fever during the first seven days, which reflects different timings of symptoms in the disease course. Data from the ZOE app shows that 31% of people who are ill with COVID-19 don't have any of the triad of symptoms in the early stages of the disease when most infectious.

The researchers applied a multi-objective evolutionary algorithm (MOEA) to generate a set of optimal symptom combinations, each characterised by a good trade-off between specificity and sensitivity. MOEA starts generating a population of random symptom combinations and then evolves that population towards better combinations ending with a set of optimal symptom combinations. The choice of the optimal combination to use depends on the testing capacity.

Cough or dyspnoea (shortness of breath) were reported by 46% of individuals positive for COVID-19 within the first three days of symptom onset. When users reported fever, the sensitivity increased to 60%, while logging anosmia/ageusia increased sensitivity to 69%. When headache and fatigue was added the proportion of COVID-19 cases increased to 92% but the tests per case doubled.

The findings may be valuable in situations where there is a limited testing capacity. Researchers suggest a range of optimal symptom combinations that could be used in vaccine efficacy trials or in public health settings, when assessing financial and logistical resources.

Professor Sebastien Ourselin from King's College London said: ""The identification of this combination of symptoms through the COVID Symptom Study app is another prime demonstration of the value of big data analytics and mobile health technology to support the management of this pandemic. Daily self-reported symptoms from a mobile application at the scale of an entire country has offered a new perspective for public health research and response towards the rapid spread of infectious diseases such as COVID-19."

Dr Claire Steves, Reader at King's College London, said: "There are many symptoms which occur in acute COVID, including some like fatigue and headache which are also common in other conditions. Depending on the testing available, different symptom combinations can be used to be as sensitive or specific as possible. We hope these models are of use in a range of settings - from vaccine trials to detecting and treating COVID outbreaks going forward."

Professor Tim Spector from King's College London said: "We've known since the beginning that just focusing testing on the classic triad of cough, fever and anosmia misses a significant proportion of positive cases. We identified anosmia as a symptom back in May and our work led to the government adding it to the list, it is now clear that we need to add more. By inviting any users who log any new symptoms to get a test, we confirmed that there are many more symptoms of COVID-19. This is especially important with new variants that may cause different symptoms. For us, the message for the public is clear: if you're feeling newly unwell, it could be COVID and you should get a test."

Dr Jakob Cramer, Head of Clinical Development, at the Coalition for Epidemic Preparedness Innovations, said: "Accurate diagnosis of COVID-19 cases is crucial when assessing the efficacy of COVID-19 vaccine candidates in large-scale studies, especially since the signs and symptoms associated with the disease are extensive and overlap with other common viral infections. The findings of this study provide important insights that will help optimise the choice of triggering symptoms for diagnostic work-up in COVID-19 vaccine-efficacy trials. We hope the findings of this study will not only aid CEPI's COVID-19 vaccine-development partners but also the wider R&D community."
-end-


King's College London

Related Fatigue Articles from Brightsurf:

Got fatigue? Study further pinpoints brain regions that may control it
Scientists at Johns Hopkins Medicine using MRI scans and computer modeling say they have further pinpointed areas of the human brain that regulate efforts to deal with fatigue.

Biomarkers link fatigue in cancer, Parkinson's
Biological markers responsible for extreme exhaustion in patients with cancer have now been linked to fatigue in those with Parkinson's disease, according to new research from Rice University.

Fatigue is a common but underestimated symptom of endometriosis
Two papers published in Human Reproduction journal show that the prevalence of fatigue is more than doubled in women with endometriosis but is underestimated, meaning that doctors should be making greater efforts to discuss and treat this debilitating symptom in these women, and that a history of some types of child abuse is linked to an increased likelihood of endometriosis in adulthood.

New 3-D display takes the eye fatigue out of virtual reality
A new type of 3-D display could solve the long-standing problem eye fatigue when using VR and AR equipment by greatly improving the viewing comfort of these wearable devices.

Chronic fatigue syndrome linked to imbalanced microbiome
Scientists at the Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.

Conquering metal fatigue
Researchers have found a way to greatly reduce the effects of fatigue in steel by incorporating a laminated nanostructure into the material.

Anakinra does not seem to improve fatigue severity in women with chronic fatigue syndrome
The anti-inflammatory biologic drug anakinra does not seem to reduce fatigue severity in women with chronic fatigue syndrome.

Reducing cancer-related fatigue
A new article published online by JAMA Oncology analyzed which of four commonly recommended treatments -- exercise, psychological, the combination of both, or pharmaceutical -- for cancer-related fatigue appeared to be most effective.

Urine test for fatigue could help prevent accidents
Doctors, pilots, air traffic controllers and bus drivers have at least one thing in common -- if they're exhausted at work, they could be putting lives at risk.

Genetic cause for shift work fatigue discovered
Some people adapt easily to shift work, but not everyone can handle constant disruptions to their daily rhythm.

Read More: Fatigue News and Fatigue Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.